Estimating Triglyceride Levels Using Total Cholesterol, Low-Density Lipoprotein Cholesterol, and High-Density Lipoprotein Cholesterol Levels: A Cross-Sectional Study
Metabolic Syndrome and Related Disorders · 01.08.2023 · 21 (6) · 327-334
DOI: 10.1089/met.2023.0045 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Metabolic Syndrome and Related Disorders, erschienen am 01.08.2023. Verfasst von Masahito Katahira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Aichi Prefectural University School of Nursing and Health, Nagoya, Japan. Hauptthemen laut MEDLINE: Cholesterol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aichi Prefectural University School of Nursing and Health, Nagoya, Japan.
- Checkup Center, Daiyukai Daiichi Hospital, Ichinomiya, Japan.
ORCID-Profile: Masahito Katahira
Zitieren
APA
Katahira, M., Imai, S., Ono, S., & Moriura, S. (2023). Estimating Triglyceride Levels Using Total Cholesterol, Low-Density Lipoprotein Cholesterol, and High-Density Lipoprotein Cholesterol Levels: A Cross-Sectional Study. Metabolic Syndrome and Related Disorders, 21(6), 327-334. https://doi.org/10.1089/met.2023.0045
Vancouver
Katahira M, Imai S, Ono S, Moriura S. Estimating Triglyceride Levels Using Total Cholesterol, Low-Density Lipoprotein Cholesterol, and High-Density Lipoprotein Cholesterol Levels: A Cross-Sectional Study. Metabolic Syndrome and Related Disorders. 2023;21(6):327-334. doi:10.1089/met.2023.0045
BibTeX
@article{Katahira2023,
author = {Katahira, Masahito and Imai, Shu and Ono, Satoko and Moriura, Shigeaki},
title = {Estimating Triglyceride Levels Using Total Cholesterol, Low-Density Lipoprotein Cholesterol, and High-Density Lipoprotein Cholesterol Levels: A Cross-Sectional Study},
journal = {Metabolic Syndrome and Related Disorders},
year = {2023},
volume = {21},
number = {6},
pages = {327--334},
doi = {10.1089/met.2023.0045}
}
EUVIMED